XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 74,593 $ 22,331
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 5,980 5,539
Depreciation and amortization 5,223 4,028
Loss on disposal of fixed assets 208 222
Impairment of lease right-of-use asset and fixed assets 0 612
Deferred taxes (1,673) 206
Accrued interest on note receivable - related party (4) (6)
Change in valuation of contingent payment liabilities (4,910) 470
Recovery of receivables, related to the Payless ShoeSource bankruptcy 0 (919)
Changes, net of acquisitions, in:    
Accounts receivable (12,872) (8,759)
Increase (Decrease) in Accounts and Other Receivables 25,181 32,491
Notes receivable - related party 102 102
Inventories 21,833 (5,141)
Prepaid expenses, income tax receivables, prepaid taxes, and other assets 9,802 (3,319)
Accounts payable and accrued expenses (80,642) 22,097
Accrued incentive compensation (10,131) (112)
Leases and other liabilities 1,774 182
Net cash (used in)/provided by operating activities (19,446) 5,042
Cash flows from investing activities:    
Capital expenditures 3,596 1,598
Payments to Acquire Intangible Assets (2,000)  
Payments to Acquire Short-term Investments 9,668 2,054
Proceeds from Sale of Short-term Investments 44,488 2,036
Net cash provided by/(used in) investing activities 29,224 (1,616)
Cash flows from financing activities:    
Tax benefit from the exercise of options 275 1,554
Payments of Distributions to Affiliates 0 (1,363)
Common stock purchased for treasury (42,399) (5,558)
Cash dividends paid on common stock (16,774) (12,425)
Net cash used in financing activities (58,898) (17,792)
Effect of Exchange Rate on Cash and Cash Equivalents (32) (296)
Net decrease in cash and cash equivalents (49,152) (14,662)
Cash and cash equivalents – beginning of period 219,499 247,864
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total $ 170,347 $ 233,202